本团队致力于屈光手术和眼表疾病的基础及临床研究，包括多名临床技术骨干及科研人员（副主任医师，主治医生，博士），能够共同协助指导研究生临床及科研的顺利进行；团队拥有多项国家级及市级课题，目前团队已发表学术论文50余篇，其中SCI收录论文30余篇；同时，团队拥有吃苦耐劳，奋发向上的精神，团结互助，共同进步。

获上海市自然科学基金项目、上海市卫健委项目、上海市科委重点基金项目、上海申康医院发展中心重大临床科技创新项目及市级医院新兴前沿技术联合攻关项目、同济大学“中央高校基本科研业务费专项基金”等多项基金资助。

近五年主持或参加的其他科研项目/课题：

(1) 上海市卫生健康委员会, 临床研究面上项目, 202240131, 软性角膜接触镜对小切口角膜基质透镜取出术的影响研究, 2023-01 至 2025-12, 10万元, 主持

(2) 上海市科学技术委员会, 上海市科学自然科学基金, 20ZR1443600, 维生素C调控ALKBH5/FOXM1促进角膜缘干细胞修复角膜碱烧伤的机制研究, 2020-07 至 2023-06, 25万元, 主持

(3) 上海申康医院发展中心, 重大临床研究项目, SHDC2020CR1043B-009, 基于人工智能的成人高度近视手术矫治策略研究, 2020-10 至 2022-09, 25万元, 主持

(4) 上海申康医院发展中心, 市级医院新兴前沿技术联合攻关项目, SHDC2018103, SMILE矫正复杂性近视及透镜再利用研究与推广, 2018-11 至 2021-11, 12万元, 结题, 主持

(5) 上海市第十人民医院临床研究青年培育项目，YNCR2C004，中低度近视患者SMILE及LASEK术后视觉质量与视觉传导通路的关联性研究，2022-1至2024-12，10万元，参与指导

(6) 上海市第十人民医院临床研究青年培育项目，SHYCS08，SMILE手术对青年近视眼底微血管影响的临床研究  2019-09至2022-08，10万元，参与指导

近5年代表性论著

(1) Yun, Zhang; Fukang, Yuan; Lin, Liu; Zufeng, Chen; Xiaoyun, Ma; Zhen, Lin; Jun, Zou; TheRole of the miR-21/SPRY2 Axis in Modulating Proangiogenic Factors, Epithelial Phenotypes, and Wound Healing in Corneal Epithelial Cells, Investigative Ophthalmology & Visual Science, 2019,60(12): 3854-3862

(2) Lin Liu; Dan Zhu; Wenzhi Ding; Ting Zhang; Xiaoyun Ma; Jun, Zou; MiRNA-21- HIF-1α-VEGF Axis is Associated with Myopic Choroidal Neovascularization in Guinea Pigs, Ophthalmic Research, 2022, 65(5): 493-505

(3) Manli Deng; Min Li; Lin Liu; Yuehui Shi; Lina Sun; Xiaoyun Ma; Jun Zou ; Proteomic profiling of human corneal stroma from long-term contact lens wearers reveals activation of inflammatory responses, Contact Lens and Anterior Eye, 2023; 46(3): 101820

(4) Min, Li; Lin, Liu; Yuehui, Shi; Lina, Sun; Xiaoyun, Ma; Jun, Zou; Age-related differences in corneal nerve regeneration after SMILE and the mechanism revealed by metabolomics, Experimental Eye Research, 2021, 209: 108665

(5) Min Li; Zufeng Chen; Lin Liu; Xiaoyun Ma; Jun, Zou; Topical Vitamin C Promotes the Recovery of Corneal Alkali Burns in Mice, Journal of Ophthalmology, 2021, 2021(3): 2406646

(6) Wei Wang, Jun Zou. Recent progress in N6-methyladenosine modification in ocular surface diseases,Int J Ophthalmol, 2023; 16(4): 645-651.

(7) Yiyong Qian, Dan Zhou, Dan Zhu, Tingli Shi, Jun Zou, Xiaoyun Ma. Evaluation of Corneal and Retinal Toxicity in Rheumatoid Arthritis Patients Treated with Hydroxychloroquine, Ophthalmic Res, 2022; 65(6): 659-667.  

(8) Min Li, Lin Liu, Chen Qu, Yuehui Shi, Lina Sun, Xingtao Zhou, Jun Zou. Metabolomic Analysis in Corneal Lenticules From Contact Lens Wearers,J Refract Surg, 2020, 36(5): 317-325.

(9) Lin Liu , Min Li, Yue-Hui Shi, Li-Na Sun, Fang Wang, Jun Zou. Comparison of Higher-Order Aberrations after LASEK between Two Different Laser Platforms for Low-to-Moderate Myopia,Curr Eye Res, 2020,45(9):1036-1042.

(10) Yiyong Qian, Lin Liu, Yuehui Shi, Minli Wang, Min Li, Jun Zou. Assessment of Anterior Chamber by Ultrasound Biomicroscopy and Anterior Segment Optical Coherence Tomography in Patients with Inflammatory Glaucoma, J Int Med Res, 2019, 47(12): 5950-5956.

(11) Xiaoyun Ma, Yun Zhang, Dan Zhu, Zufeng Chen, Manshan Xu, Linping He, Tingli Shi, Lvzhen Huang, Jun Zou. Low dosage chloroquine protects retinal ganglion cells against glutamate-induced cell death, Exp Eye Res, 2019: 181: 285-293.  

(12) Min Li, Yuehui Shi, Lina Sun, Lin Liu, Chen Qu, Jun Zou. Clinical Evaluation of LASEK for High Myopia Correction between the Triple-A Profile and the Zyoptix Tissue Saving Profile, J Ophthalmol, 2019: 2019: 6936042.